[Answered] In private water supply systems, water is drawn from ____

This topic contains a solution. Click here to go to the answer

Author Question: In private water supply systems, water is drawn from _____. a. a well b. a reservoir c. rivers ... (Read 414 times)

Pea0909berry

Hero Member
Posts: 573

on: Jul 24, 2018

In private water supply systems, water is drawn from _____.

a. a well
b. a reservoir
c. rivers or lakes
d. the municipal system

Question 2

The bearing defect that is caused by vibration between the rollers in the bearing raceway is _____.

a. a broken cam
b. brinelling
c. false brinelling
d. fatigue

Need homework help now?

Ask unlimited questions for free

Ask a Question

Marked as best answer by a Subject Expert

miss.ashley

Sr. Member
Posts: 371

Reply #1 on: Jul 24, 2018

Answer to Question 1

a

Answer to Question 2

c

Pea0909berry

Member
Posts: 573

Reply 2 on: Jul 24, 2018

Gracias!

bassamabas

Member
Posts: 294

Reply 3 on: Yesterday

Excellent

« previous next »

Did you know?

Drugs are in development that may cure asthma and hay fever once and for all. They target leukotrienes, which are known to cause tightening of the air passages in the lungs and increase mucus productions in nasal passages.

Did you know?

Barbituric acid, the base material of barbiturates, was first synthesized in 1863 by Adolph von Bayer. His company later went on to synthesize aspirin for the first time, and Bayer aspirin is still a popular brand today.

Did you know?

Addicts to opiates often avoid treatment because they are afraid of withdrawal. Though unpleasant, with proper management, withdrawal is rarely fatal and passes relatively quickly.

Did you know?

Though methadone is often used to treat dependency on other opioids, the drug itself can be abused. Crushing or snorting methadone can achieve the opiate "rush" desired by addicts. Improper use such as these can lead to a dangerous dependency on methadone. This drug now accounts for nearly one-third of opioid-related deaths.

Did you know?

As of mid-2016, 18.2 million people were receiving advanced retroviral therapy (ART) worldwide. This represents between 43–50% of the 34–39.8 million people living with HIV.